Repeated treatment with SA4503, a selective sigma1 receptor agonist, up-regulates α1-adrenergic system.: A behavioral study

被引:0
|
作者
Skuza, G [1 ]
Kolasiewicz, W [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Pharmacol, PL-31343 Krakow, Poland
来源
POLISH JOURNAL OF PHARMACOLOGY | 2001年 / 53卷 / 05期
关键词
sigma; agonist; repeated treatment; phenylephrine; clonidine; behavioral models;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The obtained results indicate that SA4503, a selective sigma(1) receptor agonist, given repeatedly (but not acutely) enhanced the effects of phenylephrine, alpha (1)-adrenoceptor agonist, and clonidine (stimulating the postsynaptic alpha (1)-adrenoceptors at high dose) in behavioral models (hyperexploratory activity in rats and aggressiveness in mice, respectively).
引用
收藏
页码:547 / 550
页数:4
相关论文
共 32 条
  • [21] A feasibility study of [11C]SA4503-PET for evaluating sigma1 receptor occupancy by neuroleptics: The binding of haloperidol to sigma1 and dopamine D2-like receptors
    Kiichi Ishiwata
    Kenji Oda
    Muneyuki Sakata
    Yuichi Kimura
    Kazunori Kawamura
    Keiichi Oda
    Toru Sasaki
    Mika Naganawa
    Kunihiro Chihara
    Yoshiro Okubo
    Kenji Ishii
    Annals of Nuclear Medicine, 2006, 20 : 569 - 573
  • [22] A feasibility study of [11C]SA4503-PET for evaluating sigma1 receptor occupancy by neuroleptics:: the binding of haloperidol to sigma1 and dopamine D2-like receptors
    Ishiwata, Kiichi
    Oda, Kenji
    Sakata, Muneyuki
    Kimura, Yuichi
    Kawamura, Kazunori
    Oda, Keiichi
    Sasaki, Toru
    Naganawa, Mika
    Chihara, Kunihiro
    Okubo, Yoshiro
    Ishii, Kenji
    ANNALS OF NUCLEAR MEDICINE, 2006, 20 (08) : 569 - 573
  • [23] Studies on drug dependence (Rept. 490): Effect of the sigma-1 receptor agonist SA4503 on the oxaliplatin- and paclitaxel-induced allodynia in rats
    Masumoto, Aki
    Mori, Tomohisa
    Harumiya, Masato
    Oya, Jumpei
    Fukase, Mika
    Shibasaki, Masahiro
    Suzuki, Tsutomu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 185P - 185P
  • [24] Adiponectin up-regulates the decrease of myocardial autophagic flux induced by β1-adrenergic receptor autoantibody partly dependent on AMPK
    Sun, Cong
    Lu, Jiebei
    Long, Yaolin
    Guo, Shuai
    Jia, Weiwei
    Ning, Na
    Hao, Haihu
    Wang, Xiaohui
    Bian, Yunfei
    Liu, Huirong
    Wang, Li
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (17) : 8464 - 8478
  • [25] The Reversal Effect of Sigma-1 Receptor (S1R) Agonist, SA4503, on Atrial Fibrillation After Depression and Its Underlying Mechanism (vol 10, 1346, 2019)
    Liu, Xin
    Qu, Chuan
    Shi, Shaobo
    Ye, Tianxin
    Wang, Linglin
    Liu, Steven
    Zhang, Cui
    Liang, Jinjun
    Hu, Dan
    Yang, Bo
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [26] Successful treatment of the erythema and flushing of rosacea using a topically applied selective α1-Adrenergic receptor agonist, Oxymetazoline
    Sharder, Stuart D.
    Ondo, Andrew L.
    ARCHIVES OF DERMATOLOGY, 2007, 143 (11) : 1369 - 1371
  • [27] Adenosine A1 receptor agonist treatment up-regulates rat brain metabotropic glutamate receptors
    Albasanz, JL
    León, D
    Ruíz, MA
    Fernández, M
    Martín, M
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1593 (01): : 69 - 75
  • [28] The selective σ1 receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl) piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats
    Horan, B
    Gardner, EL
    Dewey, SL
    Brodie, JD
    Ashby, CR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 426 (1-2) : R1 - R2
  • [29] SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression
    Tuerxun, Tuerhong
    Numakawa, Tadahiro
    Adachi, Naoki
    Kumamaru, Emi
    Kitazawa, Hiromi
    Kudo, Motoshige
    Kunugi, Hiroshi
    NEUROSCIENCE LETTERS, 2010, 469 (03) : 303 - 308
  • [30] Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial
    Agamia, Naglaa
    Essawy, Marwa
    Kassem, Amira
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 904 - 909